Liu, Ying
Ye, Ling
Lin, Fang
Gomaa, Yasmine
Flyer, David
Carrion, Ricardo Jr. http://orcid.org/0000-0001-7046-7683
Patterson, Jean L. http://orcid.org/0000-0001-8069-8098
Prausnitz, Mark R.
Smith, Gale
Glenn, Gregory
Wu, Hua
Compans, Richard W.
Yang, Chinglai
Funding for this research was provided by:
China Scholarship Council
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI093406, AI093406, AI093406, AI093406, AI093406, AI093406, AI093406, AI093406)
Article History
Received: 16 January 2018
Accepted: 17 May 2018
First Online: 25 July 2018
Change Date: 22 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-023-40413-0
Competing Interests
: Mark R Prausnitz from Georgia Institute of Technology is an inventor of patents licensed to companies developing microneedle-based products, is a paid advisor to companies developing microneedle-based products, and is a founder/shareholder of companies developing microneedle-based products (Micron Biomedical). This potential conflict of interest has been disclosed and is managed by Georgia Tech. Authors from Novavax, Inc., David Flyer, Gregory Glenn, and Gale Smith, are current or past employees of for profit organizations and authors own stock or hold stock options. The authors have submitted and pending patent applications related to the work. These interests do not alter the author’s adherence to policies on sharing data and materials.